Ozempic
- The researchers found that the patients who received GLP-1 agonists had a significantly lower risk of developing 10 out of 13 cancers studied
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.